BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15695381)

  • 61. Reduction of p53 dosage renders mice hypersensitive to 7, 12-dimethylbenz(alpha) anthracene-induced salivary gland tumorigenesis.
    Ide F; Kitada M; Sakashita H; Kusama K
    Anticancer Res; 2003; 23(1A):201-4. PubMed ID: 12680213
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Loss of TRAIL-R does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant mice.
    Yue HH; Diehl GE; Winoto A
    Cell Death Differ; 2005 Jan; 12(1):94-7. PubMed ID: 15514675
    [No Abstract]   [Full Text] [Related]  

  • 63. Severe ocular abnormalities in C57BL/6 but not in 129/Sv p53-deficient mice.
    Ikeda S; Hawes NL; Chang B; Avery CS; Smith RS; Nishina PM
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1874-8. PubMed ID: 10393064
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice.
    Philipp-Staheli J; Kim KH; Payne SR; Gurley KE; Liggitt D; Longton G; Kemp CJ
    Cancer Cell; 2002 May; 1(4):355-68. PubMed ID: 12086850
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Isoforms of the APC tumor suppressor and their ability to inhibit cell growth and tumorigenicity.
    Carson DJ; Santoro IM; Groden J
    Oncogene; 2004 Sep; 23(42):7144-8. PubMed ID: 15273719
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Bright note on the molecular mechanisms of oncogenic transformation].
    Blanchard JM
    Bull Cancer; 1999 Jan; 86(1):9-14. PubMed ID: 10029698
    [No Abstract]   [Full Text] [Related]  

  • 67. Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation.
    van Miltenburg MH; van Nimwegen MJ; Tijdens I; Lalai R; Kuiper R; Klarenbeek S; Schouten PC; de Vries A; Jonkers J; van de Water B
    Br J Cancer; 2014 May; 110(11):2747-55. PubMed ID: 24809783
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adenomatous polyposis coli (APC) is required for normal development of skin and thymus.
    Kuraguchi M; Wang XP; Bronson RT; Rothenberg R; Ohene-Baah NY; Lund JJ; Kucherlapati M; Maas RL; Kucherlapati R
    PLoS Genet; 2006 Sep; 2(9):e146. PubMed ID: 17002498
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Apc mutation enhances PyMT-induced mammary tumorigenesis.
    Prosperi JR; Khramtsov AI; Khramtsova GF; Goss KH
    PLoS One; 2011; 6(12):e29339. PubMed ID: 22216254
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Apc and p53 interaction in DNA damage and genomic instability in hepatocytes.
    Méniel V; Megges M; Young MA; Cole A; Sansom OJ; Clarke AR
    Oncogene; 2015 Jul; 34(31):4118-29. PubMed ID: 25347740
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency.
    Cheng L; Zhou Z; Flesken-Nikitin A; Toshkov IA; Wang W; Camps J; Ried T; Nikitin AY
    Oncogene; 2010 Oct; 29(42):5700-11. PubMed ID: 20676140
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas.
    O'Leary KA; Rugowski DE; Sullivan R; Schuler LA
    Oncogene; 2014 Jun; 33(23):3075-82. PubMed ID: 23873024
    [TBL] [Abstract][Full Text] [Related]  

  • 73. APC haploinsufficiency coupled with p53 loss sufficiently induces mucinous cystic neoplasms and invasive pancreatic carcinoma in mice.
    Kuo TL; Weng CC; Kuo KK; Chen CY; Wu DC; Hung WC; Cheng KH
    Oncogene; 2016 Apr; 35(17):2223-34. PubMed ID: 26411367
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Src transformation of colonic epithelial cells: enhanced anchorage-independent growth in an Apc(+/min) background.
    Constancio-Lund SS; Brabek J; Hanks SK
    Mol Carcinog; 2009 Feb; 48(2):156-66. PubMed ID: 18613032
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Analyzing tumor suppressor activities in the murine small intestine.
    Clarke AR; Sansom OJ
    Oncol Res; 2003; 13(6-10):333-7. PubMed ID: 12725522
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characteristic microscopic differences in the adenohypophysis of high and low mammary tumor strains of mice.
    Keramidas GD; Symeonidis A
    Pathol Eur; 1973; 8(1):35-6. PubMed ID: 4728790
    [No Abstract]   [Full Text] [Related]  

  • 77. Normal meiotic recombination in p53-deficient mice.
    Gersten KM; Kemp CJ
    Nat Genet; 1997 Dec; 17(4):378-9. PubMed ID: 9398833
    [No Abstract]   [Full Text] [Related]  

  • 78. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells.
    Fujiwara T; Bandi M; Nitta M; Ivanova EV; Bronson RT; Pellman D
    Nature; 2005 Oct; 437(7061):1043-7. PubMed ID: 16222300
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of transformation of mammary preneoplastic nodules to tumor in C3H mice fed a phenylalanine-deficient diet.
    Hui YH; DeOme KB; Briggs GM
    J Natl Cancer Inst; 1971 Jul; 47(1):245-51. PubMed ID: 5570119
    [No Abstract]   [Full Text] [Related]  

  • 80. Different phenotypic consequences of simultaneous versus stepwise Apc loss.
    Fischer JM; Miller AJ; Shibata D; Liskay RM
    Oncogene; 2012 Apr; 31(16):2028-38. PubMed ID: 21892206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.